Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2โ€“5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

CJC-1295: Modified GRF(1-29) with and without DAC

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) based on the first 29 amino acids of native GRF (sermorelin). Two forms are commonly encountered in research: CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF) and CJC-1295 with DAC (Drug Affinity Complex).

Without DAC (Mod GRF 1-29)

This version incorporates four amino acid substitutions (positions 2, 8, 15, and 27) that protect the peptide from enzymatic cleavage by DPP-IV. The result is a half-life of approximately 30 minutes compared to native GRF’s ~7 minutes, while preserving the pulsatile GH release pattern.

With DAC

The DAC (Drug Affinity Complex) version adds a lysine-linked maleimidopropionamide moiety that covalently binds to serum albumin after injection. This extends the half-life to approximately 6โ€“8 days, producing a continuous elevation of GH levels rather than pulsatile release.

Research Considerations

The choice between DAC and no-DAC variants affects experimental design. The pulsatile pattern of CJC-1295 without DAC more closely mimics physiological GH secretion, while the DAC version provides sustained receptor activation useful for studying chronic GH elevation effects.